Overview
Updated 14 Jul 2026
Kathleen N. Moore, MD, is Professor, Department of Obstetrics and Gynecology at University of Nebraska Medical Center, Fred & Pamela Buffett Cancer Center (Omaha, NE). The public record shows 1,026 publications with 47,487 citations (h-index 84), centered on Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Endometrial and Cervical Cancer Treatments. It also documents an investigator role on 21 registered clinical trials, industry payments reported by 41 companies, 6 NIH-funded awards (2017–2026).
- Most recent indexed publication: 2026 · Nature reviews. Clinical oncology
- Top research focus: Ovarian cancer diagnosis and treatment
- 21 registered trials on ClinicalTrials.gov
- Open Payments reporting from 41 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 39 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 336.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 21 registered studies on ClinicalTrials.gov. The most recent:
- Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Sponsor: Washington University School of Medicine
InvestigatorPhase 1RecruitingNCT06795009 - A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer
Sponsor: Bio-Thera Solutions
InvestigatorPhase 1/PHASE2WithdrawnNCT06545617 - Uterine Preservation Via Lifestyle Transformation
Sponsor: Washington University School of Medicine
InvestigatorPhase 2RecruitingNCT05903131
Industry payments
Updated 14 Jul 2026
41 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20255 payments$25,108openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202512 payments$23,661openpaymentsdata.cms.gov ↗
- Daiichi Sankyo Company LTDProgram year20257 payments$21,456openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Jul 2026
6 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Antibody-drug conjugates in gynaecological cancers: opportunities and challenges.
Nature reviews. Clinical oncology
2026 - New standards and new constraints redefine treatment sequencing in platinum-resistant ovarian cancer.
Nature reviews. Clinical oncology
2026 - Decoding the End Points of Poly (ADP-ribose) Polymerase Inhibitor Trials in Ovarian Cancer.
Journal of clinical oncology
2025
Most-cited worksby citation count (OpenAlex)
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MD
University of Washington School of Medicine, Seattle, WA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - MS in Epidemiology
University of Oklahoma Health Sciences Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - Residency in Obstetrics and Gynecology
Magee-Womens Hospital, University of Pittsburgh Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - Fellowship in Gynecologic Oncology
University of Oklahoma Health Sciences Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asco.org ↗
- Member
Board of Directors, American Society of Clinical Oncology (ASCO); began a four-year term in the Designated Surgical Oncologist seat starting June 2023
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →connection.asco.org ↗ - Member
Board of Directors, GOG Foundation (Gynecologic Oncology Group Foundation)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocrahope.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertperspectives.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertperspectives.com ↗
Secondary affiliationsappointments beyond the home institution
- Virginia Kerley Cade Endowed Chair in Cancer Development and Professor of Gynecologic Oncology
University of Oklahoma Health Sciences Center / OU Health Stephenson Cancer Center (prior institution …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocrahope.org ↗ - Former Deputy Director and Associate Director for Clinical Research
OU Health Stephenson Cancer Center; former Director, Oklahoma TSET Phase I Program (Oklahoma City)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- ResearchGate
researchgate.net/scientific-contributions/Kathleen-N-Moore-39995420
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Other
ocrahope.org/about/team/scientific-advisory-committee/kathleen-moore
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocrahope.org ↗ - Other
unmc.edu/newsroom/2026/03/18/kathleen-moore-md-appointed-cancer-centers-deputy-director
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/gynecologic-oncology-interview-with-kathleen-moore-md/id699146770
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Coleman, MD
Texas Oncology
- 1,362
- publications
- 105
- h-index
- 16
- trials
Bradley Monk, MD
Florida Cancer Specialists & Research Institute
- 1,001
- publications
- 94
- h-index
- 18
- trials
Carol Aghajanian, MD
Memorial Sloan Kettering Cancer Center
- 849
- publications
- 88
- h-index
- 11
- trials
Richard Penson, MD
Massachusetts General Hospital
- 394
- publications
- 68
- h-index
- 9
- trials